Dr. Dominic Balog-Way is a postdoctoral Research Associate at the King’s Centre for Risk Management. His interdisciplinary research examines the governance of risks (assessment, management and communication) to human health and the environment in North America and Europe.
He has previously led international policy-oriented research projects in a wide range of sectors and presented his work across Europe and North America at government authorities, international societies, and major universities (e.g. Cornell, Cambridge, George Washington).
He is Chair of the Risk Policy & Law speciality group at the Society for Risk Analysis (SRA) and member of the International Society for Pharmacoepidemiology (ISPE).
For his PhD, Dominic carried out comprehensive theoretical and empirical research on the impact and effectiveness of government transparency policies, with an emphasis on the global pharmaceutical sector and the European Medicines Agency. He holds a Master of Science in Risk Analysis (Distinction) and Bachelor of Arts in Geography (First Class) both from King’s.
- Risk perception and decision making science
- Evidence-based risk regulation, management and communication
- Government transparency and open data policies
- Big data and healthcare quality in high-income countries
- Uncertainty in risk management and assessment
Dominic is particularly interested in technological risks such as those associated with pharmaceuticals, food safety, climate change, and healthcare, as well as major scientific issues relating to big data, evidence-based policymaking, and transparency.
For a full list of publications, please see Dominic's research profile.
Please see Dominic's Research Staff Profile for further details.